USSTOCK.TODAY
Weekend. Closed
Log in Sign up

XORTX Therapeutics Inc(XRTX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today

XRTX
XRTX
XORTX Therapeutics Inc
At close Nov 13 at 4:00 PM ET (Korea 11/14 06:00)
$1.10
+0.18 ▲ +19.57%
Nov 13 at 7:57 PM ET (Korea 11/14 09:57)
$1.06
-0.04 ▼ -3.64%

Full metrics table

Index ⓘ -P/E ⓘ -EPS (ttm) ⓘ -2.74Insider Own ⓘ 7.84%Shs Outstand ⓘ 1.7MPerf Week ⓘ 20.88%
Market Cap ⓘ 0.00BForward P/E ⓘ -EPS next Y ⓘ -Insider Trans ⓘ -Shs Float ⓘ 1.7MPerf Month ⓘ -22.54%
Enterprise Value ⓘ 0.00BPEG ⓘ -EPS next Q ⓘ -Inst Own ⓘ 2.2%Short Float ⓘ 7.34%Perf Quarter ⓘ -46.6%
Income ⓘ -0.00BP/S ⓘ -EPS this Y ⓘ -Inst Trans ⓘ 1.3%Short Ratio ⓘ 0.17Perf Half Y ⓘ -57.53%
Sales ⓘ 0.00BP/B ⓘ 0.35EPS next 5Y ⓘ -ROA ⓘ -83.78%Short Interest ⓘ 0.12MPerf YTD ⓘ -60.85%
Book/sh ⓘ 3.18P/C ⓘ 2.02EPS past 3/5Y ⓘ 51.52% 15.39%ROE ⓘ -99.24%52W High ⓘ -69.44% ($3.60)Perf Year ⓘ -60.65%
Cash/sh ⓘ 0.55P/FCF ⓘ -Sales past 3/5Y ⓘ -ROIC ⓘ -67.93%52W Low ⓘ 32.53% ($0.83)Perf 3Y ⓘ -92.36%
Dividend Est. ⓘ -EV/EBITDA ⓘ -EPS Y/Y TTM ⓘ -1.91%Gross Margin ⓘ -Volatility(W/M) ⓘ 18.71% 15.15%Perf 5Y ⓘ -99.11%
Dividend TTM ⓘ -EV/Sales ⓘ -Sales Y/Y TTM ⓘ -Oper. Margin ⓘ -ATR (14) ⓘ 0.16Perf 10Y ⓘ -
Dividend Ex-Date ⓘ -Quick Ratio ⓘ 3.59EPS Q/Q ⓘ -10.34%Profit Margin ⓘ -RSI (14) ⓘ 47.81Recom ⓘ 1
Dividend Gr. 3/5Y ⓘ -Current Ratio ⓘ 3.59Sales Q/Q ⓘ -SMA20 ⓘ 13.06% ($0.97)Beta ⓘ 0.81Target Price ⓘ $70
Payout ⓘ -Debt/Eq ⓘ 0Earnings ⓘ 2026/8/17SMA50 ⓘ -25.15% ($1.47)Rel Volume ⓘ 2.21Prev Close ⓘ $0.92
Employees ⓘ 3LT Debt/Eq ⓘ 0EPS/Sales Surpr. ⓘ -SMA200 ⓘ -45.95% ($2.04)Avg Volume(3M) ⓘ 0.72MPrice ⓘ $1.1
IPO ⓘ 2018/11/28Option/Short ⓘ No/YesTrades ⓘ 4565Volume ⓘ 1,596,012Change ⓘ 19.57%
Company
XRTX XRTXXORTX Therapeutics Inc | NASD | Biotechnology Deep dive

🩺 This is a Canada-based micro-cap clinical-stage biotech developing treatments for chronic kidney disease and gout, targeting uric acid metabolism. Its lead programs are XORLO™ (XRx-026), a gout treatment based on the xanthine oxidase inhibitor oxypurinol, and XRx-008, a treatment for autosomal dominant polycystic kidney disease (ADPKD).

Quote

Over the past 1 year, on the lower side

69% below its 1-year high.

Now $1.10
52w low$0.8352w high$3.60
52W Range10%
Volume ⓘ 1,596,012

Traded more than usual. That is 221% of its average volume.

D
Overall · many cautions
We judged 3 of the 8 questions below. 2 need caution.
No data for growth, valuation, earnings, outlook, dividends, or not applicable.
Peer comparison Biotechnology

It ranks #574 of 598 in the industry

Based on market cap of $2M.

FAQ

FAQ

What kind of company is XRTX?

XRTX belongs to the Healthcare sector and operates in the Biotechnology industry.

What is the market cap of XRTX?

The market cap of XRTX is approximately $2M, ranking 5,789 within its sector.

What is the 52-week high and low for XRTX?

XRTX has recorded a 52-week high of $3.60 and a low of $0.83.

Telegram KakaoTalk
Briefs · earnings · signals, first Telegram · KakaoTalk channels